Article
A single nucleotide polymorphism in CHAT influences response to acetylcholinesterase inhibitors in Alzheimer's disease.
Pharmacogenetics and genomics - 1 Feb 2006
Harold Denise, Macgregor Stuart, Patterson Cathryn E, Hollingworth Paul, Moore Pamela, Owen Michael J, Williams Julie, O'Donovan Michael, Passmore Peter, McIlroy Stephen, Jones Lesley
Abstract excerpt
BACKGROUND: Alzheimer's disease (AD) is a devastating neurodegeneration with a characteristic deficit in cholinergic neurotransmission. Treatment with acetylcholinesterase (AChE) inhibitors aims to reverse this deficit and does ameliorate the decline in cognition in some AD patients, although response is variable. OBJECTIVE: To examine whether sequence variation in the gene encoding choline acetyltransferase...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
